Compass Pathways' Phase IIb psilocybin trial shows reduced depression symptoms - Endpoints News

Submitted by Anonymous (not verified) on Tue, 11/09/2021 - 12:43

Compass Pathways' Phase IIb psilocybin trial shows reduced depression symptoms  Endpoints News